Should morbidity replace mortality as an endpoint for clinical trials in intensive care?
- 1 February 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 345 (8946) , 369-371
- https://doi.org/10.1016/s0140-6736(95)90347-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Why have new effective therapies for sepsis not been developed?Critical Care Medicine, 1994
- Enteral nutrition in the critically ill patient: A critical review of the evidenceIntensive Care Medicine, 1993
- Tumour-necrosis-factor antibody treatment in Crohn's diseaseThe Lancet, 1993
- Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditisPublished by Elsevier ,1992
- Where is the wisdom...?BMJ, 1991
- Use and abuse of the balloon tip pulmonary artery (Swan-Ganz)® catheterCritical Care Medicine, 1990
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Reduction of Mortality in Chloramphenicol-Treated Severe Typhoid Fever by High-Dose DexamethasoneNew England Journal of Medicine, 1984
- Measuring Functional Outcomes in Chronic Disease: A Comparison of Traditional Scales and a Self- Administered Health Status Questionnaire in Patients With Rheumatoid ArthritisMedical Care, 1983
- Effect of Preoperative Neornycin-Erythromycin Intestinal Preparation on the Incidence of Infectious Complications Following Colon SurgeryAnnals of Surgery, 1973